These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10903384)

  • 1. Therapeutic radiopharmaceuticals.
    Ercan MT; Caglar M
    Curr Pharm Des; 2000 Jul; 6(11):1085-121. PubMed ID: 10903384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.
    Boyd M; Ross SC; Dorrens J; Fullerton NE; Tan KW; Zalutsky MR; Mairs RJ
    J Nucl Med; 2006 Jun; 47(6):1007-15. PubMed ID: 16741311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic radionuclides: production and decay property considerations.
    Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
    J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
    Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
    Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
    Aghevlian S; Boyle AJ; Reilly RM
    Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different classes of radionuclides for potential use in radioimmunotherapy.
    Karagiannis TC
    Hell J Nucl Med; 2007; 10(2):82-8. PubMed ID: 17684582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radiobiology of targeted radiotherapy.
    Wheldon TE; O'Donoghue JA
    Int J Radiat Biol; 1990 Jul; 58(1):1-21. PubMed ID: 1973428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-energy electron emitters for targeted radiotherapy of small tumours.
    Bernhardt P; Forssell-Aronsson E; Jacobsson L; Skarnemark G
    Acta Oncol; 2001; 40(5):602-8. PubMed ID: 11669332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auger radiation targeted into DNA: a therapy perspective.
    Buchegger F; Perillo-Adamer F; Dupertuis YM; Delaloye AB
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1352-63. PubMed ID: 16896663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel radionuclides for medical applications.
    Qaim SM; Spahn I
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):126-140. PubMed ID: 29110328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
    Bouchet LG; Bolch WE; Goddu SM; Howell RW; Rao DV
    J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
    Boyd M; Sorensen A; McCluskey AG; Mairs RJ
    J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted radionuclide therapy--an overview.
    Dash A; Knapp FF; Pillai MR
    Curr Radiopharm; 2013 Sep; 6(3):152-80. PubMed ID: 24059327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma.
    Lee H; Riad A; Martorano P; Mansfield A; Samanta M; Batra V; Mach RH; Maris JM; Pryma DA; Makvandi M
    J Nucl Med; 2020 Jun; 61(6):850-856. PubMed ID: 31676730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steps towards cancer therapy with radionuclides--a review including radiation biophysical aspects.
    Kampf G
    Radiobiol Radiother (Berl); 1990; 31(3):215-29. PubMed ID: 2201055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy.
    Hindié E; Zanotti-Fregonara P; Quinto MA; Morgat C; Champion C
    J Nucl Med; 2016 May; 57(5):759-64. PubMed ID: 26912441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges.
    Salih S; Alkatheeri A; Alomaim W; Elliyanti A
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational evaluation of the therapeutic effect and dosimetry of auger electrons for radionuclide therapy in a cell culture model.
    Shinohara A; Hanaoka H; Sakashita T; Sato T; Yamaguchi A; Ishioka NS; Tsushima Y
    Ann Nucl Med; 2018 Feb; 32(2):114-122. PubMed ID: 29238922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer radioimmunotherapy with alpha-emitting nuclides.
    Couturier O; Supiot S; Degraef-Mougin M; Faivre-Chauvet A; Carlier T; Chatal JF; Davodeau F; Cherel M
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):601-14. PubMed ID: 15841373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of radionuclides in therapy].
    Vucina J; Han R
    Med Pregl; 2001; 54(5-6):245-50. PubMed ID: 11759220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.